Immunogenic cell death (ICD) consists of the release of damage-associated molecular patterns (DAMPs e.g., HMGB1, ATP, Type I interferons) accompanied by tumor-associated antigens (TAA) and tumor-specific antigens (TSA) that are captured and presented by antigen-presenting cells (APCs) [6,7]. The gene discussed is HMGB1; the disease is neoplasm.